MEB-55, identified by its CAS number 1323359-63-2, is a chemical compound that has garnered attention in research contexts, particularly in the field of medicinal chemistry. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds like MEB-55 are often evaluated for their potential therapeutic applications. Typically, such substances may exhibit properties like solubility in various solvents, stability under certain conditions, and specific reactivity profiles. The compound may also be assessed for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for understanding its efficacy and safety in biological systems. Additionally, MEB-55 may be studied for its interactions with biological targets, which can provide insights into its mechanism of action. As with any chemical substance, proper handling and safety protocols are essential, especially when dealing with novel compounds that may not have extensive safety data available. For detailed information, including experimental data and specific applications, consulting scientific literature or databases is recommended.

MEB55 is an anticancer agent. It acts by disrupting DNA repair and halting growth in prostate, colon, lung and breast cancer cells

MEB-55

1323359-63-2: MEB-55, identified by its CAS number 1323359-63-2, is a chemical compound that has garnered attention in research contexts, particularly in the field of medicinal chemistry. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds like MEB-55 are often evaluated for their potential therapeutic applications. Typically, such substances may exhibit properties like solubility in various solvents, stability under certain conditions, and specific reactivity profiles. The compound may also be assessed for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for understanding its efficacy and safety in biological systems. Additionally, MEB-55 may be studied for its interactions with biological targets, which can provide insights into its mechanism of action. As with any chemical substance, proper handling and safety protocols are essential, especially when dealing with novel compounds that may not have extensive safety data available. For detailed information, including experimental data and specific applications, consulting scientific literature or databases is recommended.

<p>MEB55, an anticancer agent, acts by disrupting DNA repair and halting growth in prostate, colon, lung and breast cancer cells.</p>

CAS 1323359-63-2

MEB-55

MEB55

Ref: TM-T28010